pioglitazone has been researched along with Acute Lymphoid Leukemia in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Nagayama, A | 1 |
Ashida, K | 1 |
Watanabe, M | 1 |
Moritaka, K | 1 |
Sonezaki, A | 1 |
Kitajima, Y | 1 |
Takahashi, H | 1 |
Yoshinobu, S | 1 |
Iwata, S | 1 |
Yasuda, J | 1 |
Hasuzawa, N | 1 |
Ozono, S | 1 |
Motomura, S | 1 |
Nomura, M | 1 |
1 other study available for pioglitazone and Acute Lymphoid Leukemia
Article | Year |
---|---|
Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy.
Topics: Benzhydryl Compounds; Bone Marrow Transplantation; Drug Therapy, Combination; Female; Glucosides; Hu | 2021 |